Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14924263 | 0.81 | GBA1 (0.44) | GBA1CYP19A1 | |
| SCHEMBL26431298 | 0.80 | GBA1 (0.49) | GBA1 | |
| SCHEMBL21507161 | 0.79 | GBA1 (0.45) | GBA1CYP19A1 | |
| SCHEMBL1753962 | 0.79 | GBA1 (0.45) | GBA1CYP19A1 | |
| SCHEMBL25704385 | 0.78 | GBA1 (0.44) | GBA1 | |
| SCHEMBL27307845 | 0.77 | GBA1 (0.46) | GBA1 | |
| SCHEMBL5021089 | 0.77 | CYP19A1 (0.59) | GBA1CYP19A1 | |
| SCHEMBL14925315 | 0.76 | GBA1 (0.42) | GBA1CYP19A1 | |
| SCHEMBL12224107 | 0.76 | GBA1 (0.43) | GBA1CYP19A1 | |
| SCHEMBL22280504 | 0.76 | GBA1 (0.43) | GBA1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180100146-A1 | HIGH-SPEED PHOTO-CROSS-LINKING LINKER FOR MOLECULAR INTERACTION ANALYSIS AND IN VITRO SELECTION, AND IN VITRO SELECTION METHOD USING LINKER | SAITAMA UNIVERSITY (JP) | 2018-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180100146-A1 | HIGH-SPEED PHOTO-CROSS-LINKING LINKER FOR MOLECULAR INTERACTION ANALYSIS AND IN VITRO SELECTION, AND IN VITRO SELECTION METHOD USING LINKER | RTCB, CPSF1, CPSF7 | GBA1 4586/4885CYP19A1 3598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.